Live Breaking News & Updates on Vazyme Biotech Co

Stay updated with breaking news from Vazyme biotech co. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

C-reactive Protein Testing Market Expected to Grow at 2.9% CAGR, Reaching USD 4 billion by 2031: Transparency Market Research, Inc.

Growing demand for precision medicine and biomarkers will drive C-reactive protein testing market growth.Wilmington, Delaware, United States, Feb. 15, 2024 (GLOBE NEWSWIRE) Transparency Market Research Inc. - The C-reactive protein testing market was worth US$ 3.1 billion in 2022. A CAGR of 2.9% is projected from 2023 to 2031, and the market will reach more than US$ 4.0 billion in 2031. Integrating data from diverse sources, such as genetic information, electronic health records, and real-tim ....

United States , Nikhil Sawlani , Asia Pacific , Goldsite Diagnostics Inc , Premium Research , Dxgen Corp , Laboratory Corporation Of America Holdings Labcorp , Vazyme Biotech Co , Laboratory Corporation Of America Holdings , Roche Ltd , Agilent Technologies Inc , Abbott Laboratories , Optibio Co Ltd , Biotech Inc , Transparency Market Research Inc , Getein Biotech Inc , Transparency Market Research , Market Research , North America , C Reactive Protein Testing Market , America Holdings , Fisher Scientific , C Reactive Protein , Premium Research Report , More Reports , Diagnostics Market ,

Efficient production of icariin and baohuoside I from Epimedium Folium flavonoids by fungal α-l-rhamnosidase hydrolysing regioselectively the terminal rhamnose of epimedin C | Biotechnology for Biofuels and Bioproducts

Industrial application of icariin and baohuoside I has been hindered by the short supply to a great extent. In this work, a novel GH78 α-l-rhamnosidase AmRha catalyzed the bioconversion of low-value epimedin C in crude Epimedium Folium flavonoids (EFs) to icariin and baohuoside I was developed. Firstly, the high-level expression of AmRha in Komagataella phaffii GS115 attained an enzyme activity of 571.04 U/mL. The purified recombinant AmRha could hydrolyze α-1,2-rhamnoside bond between two rhamnoses (α-Rha(2 → 1)α-Rha) in epimedin C to produce icariin with a molar conversion rate of 92.3%, in vitro. Furtherly, the biotransformation of epimedin C to icariin by the recombinant Komagataella phaffii GS115 cells was also investigated, which elevated the EFs concentration by fivefold. In addition, biotransformation of epimedins A-C and icariin in the raw EFs to baohuoside I was fulfilled by a collaboration of AmRha and β-glucosidase/β-xylosidas ....

United States , Dligase Takara , Takara Bio , Amrha Genbank , Bio Rad Aminex , Aldrich Trading Co Ltd , Technology Chengdu , Jiangsu Kanion Pharmaceutical Co , Vazyme Biotech Co , Generay Biotech Co Ltd , Shanghai Aladdin Biochemical Technology Co Ltd , Microbiology Laboratory Nanjing Forestry University , Shaanxi Tianneng Co Ltd , Chengdu Must Bio Technology , Epimedium Folium , Jiangsu Kanion Pharmaceutical , Vazyme Biotech , Microbiology Laboratory , Nanjing Forestry University , Minelute Gel Extraction Kit , Plasmid Miniprep Kit , Swiss Model , Fast Flow , Sangon Biotech ,